title: When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Seidman
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D003603:Cytotoxins / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D018579:Patient Selection; D017698:Postmenopause; D011960:Receptors, Estrogen / Q000378:metabolism*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D003603:Cytotoxins; D011960:Receptors, Estrogen